Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MercadoLibre | MELI | Sep 19, 2024 | 2 109.40 | +0.32 |
Mercantile Bank | MBWM | Sep 19, 2024 | 46.61 | +2.96 |
Mercer International | MERC | Sep 19, 2024 | 6.44 | +0.78 |
Merchants Bancorp | MBIN | Sep 19, 2024 | 47.16 | +2.92 |
Merchants Bancorp B | MBINO | Sep 19, 2024 | 25.10 | +0.06 |
Merchants Bancorp C Pref | MBINN | Sep 19, 2024 | 22.75 | +1.20 |
Merchants Bancorp Pref D | MBINM | Sep 19, 2024 | 26.72 | +0.79 |
Merck & Co | MRK | Sep 19, 2024 | 117.23 | -1.19 |
Mercurity Fintech | MFH | Sep 19, 2024 | 1.23 | +0.14 |
Mercury General | MCY | Sep 19, 2024 | 60.05 | +0.81 |
Mercury Systems | MRCY | Sep 19, 2024 | 35.56 | -2.07 |
Mereo BioPharma ADR | MREO | Sep 19, 2024 | 4.28 | +1.42 |
Meridian | MRBK | Sep 19, 2024 | 12.46 | +3.23 |
MeridianLink | MLNK | Sep 19, 2024 | 24.40 | +1.50 |
Merit Medical Systems | MMSI | Sep 19, 2024 | 100.23 | +1.54 |
Meritage Homes | MTH | Sep 19, 2024 | 213.69 | +5.49 |
Merrill Lynch & Co. | IPB | Sep 19, 2024 | 26.75 | -2.01 |
Mersana Therapeutics | MRSN | Sep 19, 2024 | 2.19 | +3.30 |
Merus N.V | MRUS | Sep 19, 2024 | 50.81 | +2.81 |
Mesa Air Group | MESA | Sep 19, 2024 | 1.23 | -2.78 |
Mesa Laboratories | MLAB | Sep 19, 2024 | 128.43 | +1.81 |
Mesa Royalty Trust | MTR | Sep 19, 2024 | 5.88 | +1.48 |
Mesabi Royalty Trust | MSB | Sep 19, 2024 | 21.75 | +2.40 |
Mesoblast ADR | MESO | Sep 19, 2024 | 6.41 | +3.55 |
Meta Data ADR | AIU | Sep 19, 2024 | 0.61 | 0.00 |
Meta Materials | MMAT | Sep 19, 2024 | 0.64 | 0.00 |
Meta Platforms A | META | Sep 19, 2024 | 559.10 | +3.93 |
Metagenomi | MGX | Sep 19, 2024 | 2.63 | -1.13 |
Metal Sky Star Acquisition | MSSA | Sep 19, 2024 | 11.40 | 0.00 |
Metalla Royalty & Streaming | MTA | Sep 19, 2024 | 3.23 | +3.86 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.